Open access · OA
via OpenAlex
Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe?
Nirmala Koju, Zheng‐Hong Qin, Rui Sheng
Acta Pharmacologica Sinica · 2022 · ▲ 89 citations
Abstract
This review article in Acta Pharmacologica Sinica 2022 examines the roles of reduced nicotinamide adenine dinucleotide phosphate in redox balance and disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41401-021-00838-7
- Canonical
- link ↗
- Fetched
- 2026-09-15 MST
Cite this
APA
Koju, N., Qin, Z., & Sheng, R. (2022). Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe?. <em>Acta Pharmacologica Sinica</em>. https://doi.org/10.1038/s41401-021-00838-7
Vancouver
Koju N, Qin Z, Sheng R. Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe?. Acta Pharmacologica Sinica. 2022. doi:10.1038/s41401-021-00838-7.
BibTeX
@article{nirmala2022Reduce,
title = {Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe?},
author = {Nirmala Koju and Zheng‐Hong Qin and Rui Sheng},
journal = {Acta Pharmacologica Sinica},
year = {2022},
doi = {10.1038/s41401-021-00838-7},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of the American Society of Hypertension 2016
Citation only
Nicotinamide nucleotide transhydrogenase activity impacts mitochondrial redox balance and the development of hypertension in mice
Molecular Neurobiology 2012
Preprint · OA
Molecular Chaperones, Alpha-Synuclein, and Neurodegeneration
Advanced Functional Materials 2025
Open access · OA
Nanopore Identification of Nicotinamide Adenine Nucleotide and Its Derivatives
Clinical and translational medicine 2026
Open access · OA
SelO-mediated nicotinamide adenine dinucleotide hydrolysis and its implications for metabolic therapies.
Circulation Research 2018
Open access · OA
Sirtuins and NAD + in the Development and Treatment of Metabolic and Cardiovascular Diseases
Clinical bioenergetics 2025
Open access · CC-BY